April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
The Ocular Hypertension Treatment Study (OHTS): Longitudinal analyses of mean deviation (MD) loss and its association with visual acuity (VA) and contrast sensitivity (CS) in eyes newly diagnosed with primary-open angle glaucoma (POAG)
Author Affiliations & Notes
  • Mae O Gordon
    Ophthal & Vis Sciences, Washington Univ Sch of Med, St Louis, MO
    Division of Biostatistics, Washington University School of Medicine, St Louis, MO
  • J Phiilip Miller
    Division of Biostatistics, Washington University School of Medicine, St Louis, MO
  • Julia Beiser
    Ophthal & Vis Sciences, Washington Univ Sch of Med, St Louis, MO
  • Michael A Kass
    Ophthal & Vis Sciences, Washington Univ Sch of Med, St Louis, MO
  • Feng Gao
    Division of Biostatistics, Washington University School of Medicine, St Louis, MO
  • Footnotes
    Commercial Relationships Mae Gordon, None; J Phiilip Miller, None; Julia Beiser, None; Michael Kass, None; Feng Gao, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5647. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mae O Gordon, J Phiilip Miller, Julia Beiser, Michael A Kass, Feng Gao, ; The Ocular Hypertension Treatment Study (OHTS): Longitudinal analyses of mean deviation (MD) loss and its association with visual acuity (VA) and contrast sensitivity (CS) in eyes newly diagnosed with primary-open angle glaucoma (POAG). Invest. Ophthalmol. Vis. Sci. 2014;55(13):5647.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

1.To use latent class analysis (LCA) to identify mutually-exclusive classes of eyes by their rate of MD loss 2.To test the association of rate of MD loss with VA and contrast sensitivity (CS).

 
Methods
 

Analysis of 13 years of data collected prospectively from 277 participants (359 eyes) that developed POAG (5 years post-POAG f/up) and 1243 participants (2480 eyes) that did not. Visual fields were performed semi-annually, ETDRS visual acuity (VA) annually and contrast sensitivity (CS) at study close-out. At least 4 VF’s were required for inclusion. Data were censored after cataract surgery. LCA was performed to divide POAG eyes into subgroups based on rate of MD loss. Bayesian Information Criterion (BIC) was used to select optimal LCA. To assess the association of MD loss with VA and CS, multivariable linear mixed-effect models were fitted to compare between-group differences in ETDRS and CS, assuming the LCA subgroups as known. For POAG eyes, length of f/up was centered at the date of POAG diagnosis and, for non-POAG eyes, at 90th month the median time of POAG diagnosis. All the mixed models allow each eye to have its own random intercept and (if included) slope.

 
Results
 

In multivariable, linear mixed-effects models, no differences between POAG and non-POAG eyes were detected in VA (52.4 vs. 52.6 letters, p=0.75) or CS (1.58 vs. 1.61, p=0.17), though POAG eyes showed slightly faster decrease in VA (-0.61 vs. -0.44 letters/year, p=0.002). LCA and BIC identified 5 classes best describing MD loss (Figure). Mixed models compared non-POAG eyes with LCA classes and found classes 4 and 5 (15% of POAG eyes) had significantly worse VA and CS compared to non-POAG eyes and classes 1&2 (Table). The estimated intercepts and slopes of MD from mixed model were also presented in the Table.

 
Conclusions
 

Overall comparisons of outcomes by POAG status may fail to detect differences affecting a small proportion of participants. LCA provided formal criteria for identifying heterogeneity among participants in whom rapid rate of MD loss was associated with loss in other visual functions.

 
 
Estimated intercepts and slopes from linear mixed models
 
Estimated intercepts and slopes from linear mixed models
 
 
MD (means, 95% CI) for 5 latent classes of MD loss
 
MD (means, 95% CI) for 5 latent classes of MD loss
 
Keywords: 459 clinical (human) or epidemiologic studies: biostatistics/epidemiology methodology • 462 clinical (human) or epidemiologic studies: outcomes/complications  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×